A circulating miRNA assay as a first-line test for prostate cancer screening

BACKGROUND: Prostate cancer (PCa) screening currently relies on prostate-specific antigen (PSA) testing and digital rectal examination. However, recent large-scale studies have questioned the long-term efficacy of these tests, and biomarkers that accurately identify PCa are needed. METHODS: We analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharova, Evgeniya, Grassi, Angela, Marcer, Anna, Ruggero, Katia, Pinto, Francesco, Bassi, Pierfrancesco, Zanovello, Paola, Zattoni, Filiberto, D'Agostino, Donna M, Iafrate, Massimo, Ciminale, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984473/
https://www.ncbi.nlm.nih.gov/pubmed/27228285
http://dx.doi.org/10.1038/bjc.2016.151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984473/
https://www.ncbi.nlm.nih.gov/pubmed/27228285
http://dx.doi.org/10.1038/bjc.2016.151

Ejemplares similares